J Neurol Surg B Skull Base 2018; 79(02): 131-138
DOI: 10.1055/s-0037-1604484
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Comparative Cost Analysis of Endoscopic versus Microscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas

Chikezie Ikechukwu Eseonu
1   Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, United States
,
Karim ReFaey
1   Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, United States
2   Department of Neurological Surgery, Mayo Clinic, Jacksonville, Florida, United States
,
Oscar Garcia
1   Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, United States
,
Roberto Salvatori
3   Department of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, Maryland, United States
,
Alfredo Quinones-Hinojosa
1   Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, United States
2   Department of Neurological Surgery, Mayo Clinic, Jacksonville, Florida, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

06. Februar 2017

17. Juni 2017

Publikationsdatum:
08. August 2017 (online)

Abstract

Objective This study presents a comparative analysis of cost efficacy between the microscopic and endoscopic transsphenoidal approaches, evaluating neurological outcome, extent of resection (EOR), and inpatient hospital costs.

Design This study was a retrospective chart review.

Setting This study was conducted at a tertiary care center.

Participants The study group consisted of 68 patients with transsphenoidal surgeries between January 2007 and January 2014.

Main Outcome Measures Two-sample t-tests and Pearson's chi-square test evaluated inpatient costs, quality-adjusted life years (QALYs), volumetric EOR, and neurological outcomes.

Results Total inpatient costs per patient was $22,853 in the microscopic group and less ($19,736) in the endoscopic group (p = 0.049). Operating room costs were $5,974 in the microscopic group and lower in the endoscopic group ($5,045; p = 0.038). Operative time was 203.6 minutes in the microscopic group and 166.3 minutes in the endoscopic group (p = 0.032). The QALY score, length of hospital stay, and postoperative outcomes were found to be similar between the two cohorts. Multivariate linear regression modeling suggested that length of stay (p < 0.001) and operative time (p = 0.008) were important factors that influenced total inpatient costs following transsphenoidal surgery.

Conclusion This study shows that transsphenoidal surgery is more cost effective with the endoscopic approach than with the microscopic approach and depends on efficiency in the operating room as well as reduction in the length of hospitalization.

 
  • References

  • 1 Barker II FG, Klibanski A, Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003; 88 (10) 4709-4719
  • 2 Lee JY, Bohman LE, Bergsneider M. Contemporary neurosurgical techniques for pituitary tumor resection. J Neurooncol 2014; 117 (03) 437-444
  • 3 Rudmik L, Starreveld YP, Vandergrift WA, Banglawala SM, Soler ZM. Cost-effectiveness of the endoscopic versus microscopic approach for pituitary adenoma resection. Laryngoscope 2015; 125 (01) 16-24
  • 4 Chien AT, Rosenthal MB. Medicare's physician value-based payment modifier--will the tectonic shift create waves?. N Engl J Med 2013; 369 (22) 2076-2078
  • 5 Shoemaker W. The cost of quality: how VBP scores correlate with hospital costs. Healthc Financ Manage 2012; 66 (10) 50-56
  • 6 McLaughlin N, Khalessi AA, Martin NA. Health care economics in neurosurgery: there is no turning back. Neurosurg Focus 2014; 37 (05) E1
  • 7 Sanai N, Quiñones-Hinojosa A, Narvid J, Kunwar S. Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors. J Neurooncol 2008; 87 (03) 317-325
  • 8 Frazier JL, Chaichana K, Jallo GI, Quiñones-Hinojosa A. Combined endoscopic and microscopic management of pediatric pituitary region tumors through one nostril: technical note with case illustrations. Childs Nerv Syst 2008; 24 (12) 1469-1478
  • 9 Eseonu CI, ReFaey K, Rincon-Torroella J. , et al. Endoscopic versus microscopic transsphenoidal approach for pituitary adenomas: comparison of outcomes during the transition of methods of a single surgeon. World Neurosurg 2017; 97: 317-325
  • 10 Martino J, Gomez E, Bilbao JL, Dueñas JC, Vázquez-Barquero A. Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas. Acta Neurochir (Wien) 2013; 155 (01) 41-50
  • 11 Eseonu CI, Rincon-Torroella J, ReFaey K, Quinones-Hinojosa A. The cost of brain surgery: awake versus asleep craniotomy for perirolandic region tumors. Neurosurgery 2017; DOI: 10.1093/neuros/nyx022.
  • 12 Chaichana KL, Jusue-Torres I, Navarro-Ramirez R. , et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 2014; 16 (01) 113-122
  • 13 Chaichana KL, Jusue-Torres I, Lemos AM. , et al. The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?. J Neurooncol 2014; 120 (03) 625-634
  • 14 Eseonu CI, Rincon-Torroella J, ReFaey K. , et al. Awake craniotomy versus craniotomy under general anesthesia for perirolandic gliomas: evaluating perioperative complications and extent of resection. Neurosurgery 2016; DOI: 10.1093/neuros/nyx023.
  • 15 Kim S, Mortaz Hedjri S, Coyte PC, Rampersaud YR. Cost-utility of lumbar decompression with or without fusion for patients with symptomatic degenerative lumbar spondylolisthesis. Spine J 2012; 12 (01) 44-54
  • 16 Parker SL, Adogwa O, Davis BJ. , et al. Cost-utility analysis of minimally invasive versus open multilevel hemilaminectomy for lumbar stenosis. J Spinal Disord Tech 2013; 26 (01) 42-47
  • 17 Doglietto F, Prevedello DM, Jane Jr JA, Han J, Laws Jr ER. Brief history of endoscopic transsphenoidal surgery–from philipp bozzini to the first world congress of endoscopic skull base surgery. Neurosurg Focus 2005; 19 (06) E3
  • 18 Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg 1997; 87 (01) 44-51
  • 19 Jho HD, Carrau RL, Ko Y, Daly MA. Endoscopic pituitary surgery: an early experience. Surg Neurol 1997; 47 (03) 213-222 ; discussion 222–223
  • 20 Liu JK, Das K, Weiss MH, Laws Jr ER, Couldwell WT. The history and evolution of transsphenoidal surgery. J Neurosurg 2001; 95 (06) 1083-1096
  • 21 Mehta GU, Lonser RR, Oldfield EH. The history of pituitary surgery for Cushing disease. J Neurosurg 2012; 116 (02) 261-268
  • 22 Little AS, Chapple K, Jahnke H, White WL. Comparative inpatient resource utilization for patients undergoing endoscopic or microscopic transsphenoidal surgery for pituitary lesions. J Neurosurg 2014; 121 (01) 84-90
  • 23 Oosmanally N, Paul JE, Zanation AM, Ewend MG, Senior BA, Ebert Jr CS. Comparative analysis of cost of endoscopic endonasal minimally invasive and sublabial-transseptal approaches to the pituitary. Int Forum Allergy Rhinol 2011; 1 (04) 242-249
  • 24 Ament J, Yang Z, Tertulien P, Shahlaie K. Comparing the cost-effectiveness of endoscopic and microscopic approaches to transphenoidal pituitary surgery. J Neurol Surg B Skull Base 2014; DOI: 10.1055/s-0034-1370450.
  • 25 Newhouse JP, Garber AM. Geographic variation in health care spending in the United States: insights from an Institute of Medicine report. JAMA 2013; 310 (12) 1227-1228
  • 26 Eseonu CI, ReFaey K, Pamias-Portalatin E. , et al. Three-hand endoscopic endonasal transsphenoidal surgery: experience with an anatomy-preserving mononostril approach technique. Oper Neurosurg 2017 DOI: https://doi.org/10.1093/ons/opx110
  • 27 Swearingen B, Wu N, Chen SY, Pulgar S, Biller BM. Health care resource use and costs among patients with cushing disease. Endocr Pract 2011; 17 (05) 681-690